Cargando…
Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems
BACKGROUND: The ability to selectively detect and target cancer cells that have undergone an epithelial-mesenchymal transition (EMT) may lead to improved methods to treat cancers such as pancreatic cancer. The remodeling of cellular glycosylation previously has been associated with cell differentiat...
Autores principales: | Maupin, Kevin A., Sinha, Arkadeep, Eugster, Emily, Miller, Jeremy, Ross, Julianna, Paulino, Vincent, Keshamouni, Venkateshwar G., Tran, Nhan, Berens, Michael, Webb, Craig, Haab, Brian B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946336/ https://www.ncbi.nlm.nih.gov/pubmed/20885998 http://dx.doi.org/10.1371/journal.pone.0013002 |
Ejemplares similares
-
Regulation of Complement Dependent Cytotoxicity by TGF-β-induced Epithelial-Mesenchymal Transition
por: Goswami, Moloy T., et al.
Publicado: (2015) -
Breaking the tolerance for tumor: Targeting negative regulators of TLR signaling
por: Standiford, Theodore J., et al.
Publicado: (2012) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
por: Keshamouni, Venkateshwar G., et al.
Publicado: (2007) -
Alteration of N-glycans and Expression of Their Related Glycogenes in the Epithelial-Mesenchymal Transition of HCV29 Bladder Epithelial Cells
por: Guo, Jia, et al.
Publicado: (2014) -
Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial–mesenchymal transition
por: Bachelder, Robin E., et al.
Publicado: (2005)